|
Nov 30, 1999
Stereotactic Ablative Radiotherapy (SABR/SBRT)
Silvia von Karstedt
Germany
Silvia von Karstedt
Speaker of: Stereotactic Ablative Radiotherapy (SABR/SBRT)
Silvia von Karstedt, PhD, is a cell biologist who specializes in the investigation of regulated cell death in cancer. For her undergraduate and graduate studies, she joined the German Cancer Research Center (DKFZ) in Heidelberg, Germany, and Imperial College London, UK, respectively. Following a postdoctoral period at University College London with Henning Walczak and the Francis Crick Institute with Julian Downward, she set up her laboratory at the University of Cologne in September 2017. Her research interests include the function of different modes of cell death in KRAS-driven cancers and in the development and treatment of small cell lung cancer (SCLC). She has published in internationally renowned scientific journals as junior and senior author, received several poster and presentation prizes and is an active editorial board member and reviewer for nature publishing group journals.
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ISLB. The mention of any product, service, organization, activity, or therapy should not be construed as an ISLB endorsement.
Recent Episodes
Nov 01, 2025
Nov 23, 2024
Nov 21, 2023
Nov 30, 1999
David MacPherson
Nov 30, 1999
Kate Sutherland
Nov 30, 1999
Portia Thomas
Nov 30, 1999
Simon Heeke
Nov 30, 1999
Bruno Paiva
Nov 30, 1999
Catherine Meador
Nov 30, 1999
Carmen Garrido
Nov 30, 1999
Heather Wakelee
